iHemo Implantable Artificial Kidney Moves One Step Closer
A $500,000 KidneyX prize will help Shuvo Roy and the UCSF team validate animal models to test the needle-free iHemo—and move toward the first human trials.
Read the full article » | Posted 08-11-2020
Related Articles
- Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
- New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
- Emerging Biomarker Research in PD Posted 03-12-2026
- Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026